A family of small plasmids encoding resistance to nucleic acid-binding (NAB) compounds has recently been identified in strains of Staphylococcus aureus isolated in Italy, Texas and Western Australia. The mol. wts of the NAB-resistance plasmids are in the range (1.5-1.9) x lo6 and all but one encode resistance to acridine yellow, ethidium bromide and quaternary ammonium compounds. The largest of the plasmids, pWG1773, differed in that it did not confer resistance to ethidium bromide. Restriction enzyme analysis of these plasmids revealed four distinct patterns corresponding to plasmids of four different mol. wts and physical maps were constructed based on the restriction patterns. Two plasmid types of molecular sizes approximately 2440 and 2240 base pairs had a 610-base pair region in common. Physical maps of the other two plasmid types were not related. The presence of a family of small NAB-resistance plasmids which carry no other known phenotypic markers provides further evidence for the strong selective advantage associated with maintenance of this determinant in clinical isolates of S. aureus.
Introduction
Plasmid-borne resistance to a range of nucleic acid-binding (NAB) compounds is a common feature of methicillin-resistant Staphylococcus aureus strains isolated in several countries (Townsend et al., 1985~) . The NAB-resistance determinant is usually found on large plasmids in association with other phenotypic markers, the most common being gentamicin resistance (Townsend et al., 1985~) .
Two NAB-resistance phenotypes have been recognised (Emslie et al., 1985a and b) which, for convenience, are designated types I and 11. The most distinguishing feature of type-I NAB resistance is the expression of resistance to diamidino compounds such as propamidine isethionate in addition to other NAB-compounds such as ethidium bromide, acridine yellow and quaternary ammonium compounds. Type-I NAB resistance is a characteristic feature of methicillin-resistant S . aureus in Eastern Australia (Emslie et al., 1985b) . Type-I1 NAB resistance does not include resistance to Received 19 Aug. 1985; accepted 11 Oct. 1985. diamidino compounds as exemplified by the NABresistance determinant located on conjugative gentamicin-resistance plasmids (Emslie et al., 1985a) .
Both Type-I and Type-I1 NAB-resistance determinants confer a "&fold increase in resistance to cetrimide and benzalkonium chloride (Emslie et al., 1985a and b) . Whether this small increase in resistance to antiseptic compounds is sufficient to provide the selective pressure for maintenance of the determinant or whether the resistance determinant contributes some other selective advantage has not been elucidated. Nevertheless, the prevalence of NAB resistance amongst current isolates of methicillin-resistant S. aureus, particularly those associated with recent outbreaks in Australia (Grubb et al., 1983; Townsend et al., 1983a, 1984a and b) , supports the suggestion that NAB resistance is an important attribute of clinical isolates of S. aureus (Townsend et al., 198%) .
We have recently identified a family of small NAB-resistance plasmids with mol. wts in the range (1 -5-1 -9) x lo6. This paper describes their phenotypic characteristics and compares their preliminary physical maps based on restriction enzyme analysis. 
Results
Ten strains of S. aureus isolated in Perth, Texas and Italy carried small plasmids range with mol. wts in the (1.5-1 '9) x lo6. After mixed-culture transfer with selection for resistance to either ethidium bromide or acridine yellow, all transcipients examined carried a small plasmid identical in mol. wt to that carried by the donor clinical isolate. The transcipients generated were resistant to the NABcompounds, cetrimide, benzalkonium chloride and acridine yellow but, like the donor strains, they were sensitive to the NAB-compound propamidine isethionate (table 1). All the transcipients were resistant to ethidium bromide with the exception of strain WG4364 which had a MIC value for ethidium bromide identical to that of the plasmid-free recipient, WGI 876.
The NAB-resistance plasmids did not confer resistance to methicillin, penicillin, gentamicin, kanamycin, neomycin, streptomycin, erythromycin, lincomycin, chloramphenicol, tetracycline, trimethoprim, spectinomycin, cadmium nitrate, mercuric chloride, phenylmercuric acetate or sodium arsenate.
Restriction enzyme analysis of the ten NABresistance plasmids revealed four distinct restriction pacterns (table 2) . Plasmids pWG1774 and pWG1772 both had a single EcoRI restriction site. Neither of these two plasmids had restriction sites for HindIII, PstI or BamHI. Plasmids pWG17, pWG32, pWG36, pWG572, pWG575, pWG1770 and pWG1771 had single restriction sites for PstI and HindIII but no restriction sites for EcoRI or BurnHI. These plasmids are represented by pWG32 (table 2) . Plasmid pWG1773 which did not confer resistance to ethidium bromide, had no restriction sites for EcoRI, Hind11 and PstI but had a single restriction site for the enzyme BamHI.
A more accurate estimate of the plasmid mol. wts was produced by electrophoresis of the linear form of the plasmids after digestion by the enzymes with a single restriction site. The molecular sizes of the four representative plasmids pWGl774, pWG 1 772, pWG32 and pWG1773 were estimated as 2440, 2240, 2360 and 2880 base pairs respectively (table  2) . TuqI restriction enzyme digestion of each of the four representative NAB-resistance plasmids generated four fragments (figs. 1-3). Plasmids pWGl774 and pWG1772 had a common TaqI fragment of molecular size 180 base pairs (table 2, fig. 1 ). However, there were no other TaqI fragments in common amongst the four plasmids. Hinfr restriction enzyme digestion of the four representative plasmids produced from two to five restriction fragments (figs. 1-3). Plasmids pWGl772 and pWG1773 both had a 590-base pair HinfI fragment. However, a Hi@-TaqI double digest of those two plasmids demonstrated that these two fragments were not identical ( figs. 1 and 3) .
Orientation and ordering of the TuqI and Hinfr restriction fragments for each plasmid was achieved with partial HinjI, partial TaqI and Hinfl-TuqI digests together with partial and complete doubledigests of the single cut restriction enzymes with both Hinfl and TaqI (table 2, figs. 1-3) . The physical maps produced by these restriction patterns revealed that plasmids pWG1774 and pWGl772 had a 610 base pair region in common which was bordered by a TaqI restriction site and the single EcoRI restriction site and encompassed one HinfI and one TuqI restriction site (fig. 4) . The physical maps of pWG32 and pWGl773 were quite distinct and had no features in common with either pWGl774 or pWGl772 ( fig. 4) .
Discussion
A family of small, (1 -5-1 -9) x lo6 mol. wt, plasmids encoding resistance to NAB compounds has been isolated from several strains of S. aureus obtained from sources in Italy, Texas and Western Australia. Plasmid-borne resistance determinants to NAB compounds are widely distributed amongst current isolates of methicillin-resistant S. aureus (Townsend et al., 198%) and are characteristic features of the strains of methicillin-resistant S. auretis associated with recent outbreaks in Eastern Australia (Grubb et al., 1983; Townsend et al.,  19834 1984a and b) . However, the NAB-resistance determinant is most frequently located on the largest plasmid of these S. aureus strains and is usually associated with resistance to gentamicin (Townsend et af., 1985~) . This is the first report of a small NAB-resistance plasmid which carries no other known phenotypic markers.
After mixed-culture transfer of the NAB-resistance plasmids. nine of the 10 transcipients expressed a type-I1 NAB-resistance phenotype. However, strain WG4364 which carried the largest plasmid, pWG 1773, showed no increased resistance to ethidium bromide despite expressing full resistance to acridine yellow and quaternary ammonium compounds. This new phenotype has been classified as type-111 NAB resistance.
The presence of three unique NAB-resistance phenotypes may reflect the existence of several genes encoding resistance to NAB compounds or it may arise from variations in phenotypic expression of the determinant. This second possibility is supported by the observation that MIC values for the NAB compounds were slightly different when similar plasmids (pWG32 and pWG 1770) were located In the two recipient backgrounds, WG1876 and WG3355 (table 1 ). Furthermore, since the clinical isolate WC3778 carried plasmid pWG 1772 and expressed Type-I11 NAB resistance, it was sensitive to ethidiurn bromide (unpublished observations). However, after transfer of plasmid pWG 1772 to the recipient strain WGI 876 (selecting for resistance to acridine yellow) the transcipient, WG4363, expressed full ethidium bromide resistance thus changing in phenotype to Type-I1 NAB resistance.
Restriction enzyme analysis revealed four distinct restriction-fragment patterns which corresponded to plasmids of four different mol. wts. Two related plasmids, pWG I 774 and pWG 1 772 of molecular sizes 2440 and 2240 base pairs respectively, were carried by strains of S . aureus isolated in Italy. These two plasmids have a region in common of c. 610 base pairs. Plasmid pWG1773, which was also isolated from an Italian strain of S. uureus, conferred type-I11 NAB resistance. Based on the preliminary physical maps, this plasmid of 2880 base pairs appeared to be unrelated to the plasmids pWG 1774 and pWGl772. The fourth unique plasmid type represented by plasmid pWG32 of 2360 base pairs was the most widespread, being carried by strains of S. aureus isolated in Perth, Houston and Rome between 1969 and 1982.
Whilst NAB-resistance determinants have more recently been found in association with gentamicin resistance, the identification of these small NABresistance plasmids in strains isolated as early as 1969 together with other early reports of NAB resistance located on a penicillinase plasmid (Ericson, 1969; Johnston and Dyke, 1969) clearly demonstrate that resistance to NAB compounds was prevalent in the S . uureu.7 population well before the emergence of gentamicin resistance. Furthermore. the maintenance for some 15 years of a NAB-resistance plasmid which confers no other known resistance phenotype and the widespread distribution of strains of S. aureus carrying such a plasmid emphasises the selective pressure operating to maintain such a resistance mechanism. Further genetic characterisation of these small plasmids will define the gene or genes responsible for NAB resistance more precisely and will make possible the comparison of these NAB-resistance determinants with those more recently found on large gentamicin-resistance plasmids. 
